Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients

Addiction Biology

Volumn 13, Issue 3-4, 2008, Pages 393-402

  Compton, Peggy A ^a   Ling, Walter ^b   Torrington, Matt A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cold pressor pain; Dextromethorphan; Electrical stimulation pain; Hyperalgesia; Methadone; Opiods

Indexed keywords

DEXTROMETHORPHAN; METHADONE; PLACEBO;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; ELECTROSTIMULATION; FEMALE; HISPANIC; HUMAN; HYPERALGESIA; MAINTENANCE THERAPY; MALE; PAIN THRESHOLD; PRIORITY JOURNAL; SEX DIFFERENCE; STUDENT T TEST;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; DEXTROMETHORPHAN; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; MALE; METHADONE; MIDDLE AGED; PAIN THRESHOLD; RECEPTORS, N-METHYL-D-ASPARTATE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 49349105620     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2008.00112.x     Document Type: Article

References (77)

1. Alford DP, Compton P, Samet JH (2006) Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med 17 : 127 134.
2. Anghelescu DL, Oakes LL (2005) Ketamine use for reduction of opioid tolerance in a 5-year-old girl with end-stage abdominal neuroblastoma. J Pain Symptom Manage 30 : 1 3.
3. Angst MS, Clark JD (2006) Opioid-induced hyperalgesia; a qualitative systematic review. Anesthesiology 104 : 570 587.
4. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M (2003) Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106 : 49 57.
5. Athanasos P, Smith CS, White JM, Somogyi AA, Bochner F, Ling W (2006) Methadone maintenance patients are cross tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain 120 : 267 275.
6. Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ (2006) NMDA-receptor antagonism during the development of morphine analgesic tolerance in male, but not female C57BL/6J mice. Am J Physiol Regul Integr Comp Physiol 291 : 315 326.
7. Campbell CM, Edwards RR, Filligim RB (2005) Ethnic differences in response to multiple experimental pain stimuli. Pain 205 : 20 26.
8. Celerier E, Laulin J, Larcher A, Le Moal M, Simonnet G (1999) Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res 847 : 18 25.
9. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simmone G (2000) Long-lasting hyperalgesia induced by fentanyl in rats. Anesthesiology 92 : 465 472.
10. Cepeda MS, Farrar JY, Roa JH, Boston R, Meng OC, Ruiz F, Carr DB, Strom BL (2001) Ethnicity influences morphine pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 70 : 351 361.
11. Chang G, Chen L, Mao J (2007) Opioid tolerance and hyperalgesia. Med Clin North Am 91 : 199 211.
12. Chaplan SR, Malmberg AB, Yaksh TL (1997) Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 280 : 829 838.
13. Chu LF, Clark DJ, Angst MS (2006) Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7 : 43 48.
14. Colpaert FC (1996) System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48 : 355 408.
15. Compton P, Charuvastra C, Kintaudi K, Ling W (2000) Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage 20 : 237 245.
16. Cornish JW, Herman BH, Ehrman RN, Robbins SJ, Childress AR, Bead V, Esmonde CA, Martiz K, Poole S, Caruso FS, O'Brien CP (2002) A randomized, double-blind, placebo-controlled safety study of high dose dextromethorphan in methadone maintained male inpatients. Drug Alcohol Depend 67 : 177 183.
17. DeLeo JA, Tanga FY, Tawfik VL (2004) Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10 : 40 52.
18. Devillers JP, Boisserie F, Laulin JP, Larcher A, Simonnet G (1995) Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res 700 : 173 181.
19. Doverty M, White J, Somogyi A, Bochner F, Ali R, Ling W (2001) Hyperalgesic responses in methadone maintained patients. Pain 90 : 91 96.
20. Drogul A, Bilsky EJ, Ossipov MH, Lai J, Porreca F (2005) Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance. Anesth Analg 101 : 1730 1735.
21. Dudgeon DJ, Bruera E, Gagnon B, Watanabe SM, Allan SJ, Warr DG, MacDonald SM, Savage C, Tu D, Pater JL (2007) A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients. J Pain Symptom Manage 33 : 365 371.
22. Duncan MA, Spiller JA (2002) Analgesia with ketamine in a patient with perioperative opioid tolerance. J Pain Symptom Manage 24 : 8 11.
23. Dyer KR, Foster DJ, White JM, Somogyi AA, Menelaou A, Bochner F (1999) Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clin Pharmacol Ther 65 : 685 694.
24. Eckhardt K, Li S, Ammon S, Schanzle G, Mikus G, Eichelbaum M (1998) Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain 76 : 27 33.
25. Edwards RR, Doleys DM, Fillingim RB, Lowery D (2001) Ethnic differences in pain tolerance: Clinical implications in a chronic pain population. Psychosom Med 63 : 316 323.
26. Edwards RR, Fillingim RB (1999) Ethnic differences in thermal pain responses. Psychosom Med 61 : 346 354.
27. Gaedigk A, Bhathena A, Ndjountché L, Pearce RE, Abdel-Rahman SW, Bradford LD, Rogan PK, Leeder JS (2005) Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans. Pharmacogenomics J 5 : 173 182.
28. Galer BS, Lee D, Ma T, Nagle B, Schlagheck TG (2005) MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 115 : 284 295.
29. Gardell LR, King T, Ossipov MH, Rice KC, Lai J, Vanderah TW, Porreca F (2006) Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett 396 : 44 49.
30. Gardell LR, Wang R, Burgess SE, Ossipov MH, Vanderah TW, Malan Jr. TP, Lai J, Porreca F (2002) Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 22 : 6747 6755.
31. Heiskanen T, Hartel B, Dahl ML, Seppala T, Kalso E (2002) Analgesic effects of dextromethorphan and morphine in patients with chronic pain. Pain 96 : 261 267.
32. Helmy SA, Bali A (2001) The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements. Anesth Analg 92 : 739 744.
33. Holtman JR, Wala EP (2005) Characterization of morphine-induced hyperalgesia in male and female rats. Pain 114 : 62 70.
34. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24 : 7353 7365.
35. Johnston IN, Westbrook RF (2005) Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia. Behav Brain Res 156 : 75 83.
36. Kest B, Sarton E, Dahan A (2000) Gender differences in opioid-mediated analgesia: animal and human studies. Anesthesiology 93 : 539 547.
37. Kim H, Neubert JK, Rowan JS, Brahim JS, Iadarola MJ, Dionne RA (2004) Comparison of experimental and acute clinical pain responses in humans as pain phenotypes. J Pain 5 : 377 384.
38. King T, Gardell LR, Wang R, Vardanyan A, Ossipov MH, Malan TP, Vanderah TW, Hunt SP, Hruby VJ, La J, Porreca F (2005a) Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 116 : 276 288.
39. King T, Ossipov MH, Vanderah TW, Porreca F, Lai J (2005b) Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 14 : 194 205.
40. Koppert W, Schmelz M (2007) The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract Res Clin Anaesthesiol 21 : 65 83.
41. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schuttler J (2003) Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 99 : 152 159.
42. Larcher A, Laulin JP, Celerier E, Le Moal M, Simonnet G (1998) Acute tolerance associated with a single opiate administration: Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84 : 583 589.
43. Laulin JP, Celerier E, Larcher A, Le Moal M, Simmonet G (1999) Letters to neuroscience: opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 : 631 636.
44. Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G (2002) The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 94 : 1263 1269.
45. Li X, Angst MS, Clark JD (2001) A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 86 : 56 62.
46. Mao J (2002) Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100 : 213 217.
47. Mao J (2006) Opioid-induced abnormal pain sensitivity. Curr Pain Headache Rep 10 : 67 70.
48. Mao J, Price D, Mayer D (1995) Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61 : 353 364.
49. Mao J, Sung B, Lim G (2002) Chronic morphine induces downregulation of spinal glutamate transporters; implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 22 : 8312 8323.
50. Mayer DJ, Mao J, Holt J, Price DD (1999) Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 96 : 7731 7736.
51. Mechlin MB, Maixner W, Light KC, Fisher JM, Girdler SS (2005) African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures. Psychosom Med 67 : 948 956.
52. Mercadante S, Ferrera P, Villari P, Arcuri E (2003a) Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 26 : 769 775.
53. Mercadante S, Villari P, Ferrera P (2003b) Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manage 25 : 302 305.
54. Mogil JS, Belknap JK (1997) Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia. Pharmacol Biochem Behav 56 : 61 66.
55. Newshan G (2000) Pain management in the addicted patient: practical considerations. Nurs Outlook 48 : 81 85.
56. Ossipov MH, Lai J, King T, Vanderah TW, Malan TP Jr., Hruby VJ, Porreca F (2004) Antinociceptive and nociceptive actions of opioids. J Neurobiol 61 : 6 148.
57. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F (2005) Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 80 : 319 324.
58. Pud D, Cohen D, Lawental E, Eisenberg E (2006) Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 82 : 218 223.
59. Raghavendra V, Rutkowski MD, DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22 : 9980 9989.
60. Rahim-Williams FB, Riley JL, Herrera D, Campbell CM, Hastie BA, Fillingim RB (2007) Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics. Pain 129 : 177 184.
61. Richebe P, Rivat C, Creton C, Laulin JP, Maurette P, Lemaire M, Simonnet G (2005) Nitrous oxide revisited: evidence for potent antihyperalgesic properties. Anesthesiology 103 : 845 854.
62. Scimeca MM, Savage SR, Portenoy R, Lowinson J (2000) Treatment of pain in methadone-maintained patients. Mt Sinai J Med 67 : 412 422.
63. Simonnet G (2005) Opioids: from analgesia to anti-hyperalgesia? Pain 118 : 8 9.
64. Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 : 389 400.
65. Sindrup SH, Jensen TS (2000) Pharmacologic treatment of pain in polyneuropathy. Neurology 55 : 915 920.
66. Song P, Zhao ZQ (2001) The involvement of glial cells in the development of morphine tolerance. Neurosci Res 39 : 281 286.
67. Sun LS (1998) Gender differences in pain sensitivity and responses to analgesia. J Gend Specif Med 1 : 28 30.
68. Tai YH, Wang YH, Wang JJ, Tao PL, Tung CS, Wong CS (2006) Amitriptyline suppresses neuroinflammation and upregulates glutamate transporters in morphine-tolerant rats. Pain 124 : 77 86.
69. Van Elstraete AC, Sitbon P, Trabold F, Mazoit JX, Benhamou D (2005) A single dose of intrathecal morphine in rats induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine. Anesth Analg 101 : 1750 1756.
70. Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Ahong CM, Zhang ET, Malan TP, Ossipov MH, Lai J, Porreca F (2000) Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 20 : 7074 7079.
71. Vanderah TW, Ossipov MH, Lai J, Malan TP Jr., Porreca F (2001a) Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 92 : 5 9.
72. Vanderah TW, Suengaga NM, Ossipov MH, Malan TP, Lai J, Porreca F (2001b) Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 21 : 279 286.
73. Vendruscolo LF, Pamplona FA, Takahashi RN (2004) Strain and sex differences in the expression of nociceptive behavior and stress-induced analgesia in rats. Brain Res 1030 : 277 283.
74. Watkins LR, Maier SF (2000) The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 51 : 29 57.
75. Weinbroum AA, Gorodezky A, Niv D, Ben-Abraham R, Rudick V, Szold A (2001) Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia. Can J Anaesth 48 : 167 174.
76. Wilder-Smith OH, Arendt-Nielsen L (2006) Postoperative hyperalgesia: its clinical importance and relevance. Anesthesiology 104 : 601 607.
77. Xie JY, Herman DS, Stiller CO, Gardell LR, Ossipov MH, Lai J, Porreca F, Vanderah TW (2005) Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 25 : 409 416.